
Athira Pharma (ATHA) Earnings Dates & Reports
Athira Pharma (ATHA) Most Recent Earnings
Report DateFeb 27, 2025
Period EndingQ4 2024
Est. EPS-$0.53
Actual EPS-$0.39
EarningsBeat
Athira Pharma (ATHA) Earnings
View the latest Athira Pharma (ATHA) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Athira Pharma (ATHA)
Order type
Buy in
Order amount
Est. shares
0 shares
Athira Pharma (ATHA) Earnings per Share (EPS) History
Signup for full accessBrowse free
Athira Pharma (ATHA) Latest Earnings
The value each ATHA share was expected to gain vs. the value each share gained.
Athira Pharma (ATHA) reported its most recent earnings on Feb 27, 2025 for Q4 2024, posting earnings per share (EPS) of -$0.39. This exceeded analysts' expectations of -$0.53 by 26.42%, marking a Beat.
For comparison, Athira Pharma reported EPS of -$0.71 in the same quarter last year.
The company is expected to announce its next earnings report on 07/31/2025, with analysts projecting an EPS of -$0.18.
Athira Pharma (ATHA) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Jul 31, 2025 | -$0.18 | Next earnings call Jul. 31, 2025 | ||
Q1 2025May 9, 2025 | – | -$0.23 | — | |
Q4 2024Feb 27, 2025 | -$0.53 | -$0.39 | -26.42% | |
Q3 2024Nov 7, 2024 | -$0.69 | -$0.75 | +8.70% | |
Q2 2024Aug 1, 2024 | -$0.74 | -$0.70 | -5.41% | |
Athira Pharma (ATHA) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Athira Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 9, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Nov 7, 2024 | — | — | — |
Aug 1, 2024 | — | — | — |
Athira Pharma (ATHA) Earnings FAQs
Athira Pharma (ATHA) last reported earnings on Feb 27, 2025 for Q4 2024, posting an EPS of -$0.39, which Beat the estimate of -$0.53 by 26.42%.
For Q4 2024, Athira Pharma (ATHA) reported an EPS of -$0.39, exceeding analysts' estimate of -$0.53 by 26.42%.
For Q4 2024, Athira Pharma (ATHA) Beat expectations with an actual EPS of -$0.39 vs. an estimated EPS of -$0.53.
Following the last earnings report on Feb 27, 2025, Athira Pharma (ATHA)'s stock price moved — from — to —.
The next Athira Pharma (ATHA) earnings call is scheduled for Jul. 31, 2025, where executives will discuss financial results and outlook.